Lupin, Boehringer Ingelheim to co-market linagliptin in India
Drug majors Lupin and Boehringer Ingelheim on Wednesday announced a strategic alliance to co-market anti-diabetes drug linagliptin in India.
Oct 14, 2015, 12:04 PM IST
Drug majors Lupin and Boehringer Ingelheim on Wednesday announced a strategic alliance to co-market anti-diabetes drug linagliptin in India.
Oct 14, 2015, 12:04 PM IST